For: | Alqifari SF, Alkomi O, Esmail A, Alkhawami K, Yousri S, Muqresh MA, Alharbi N, Khojah AA, Aljabri A, Allahham A, Prabahar K, Alshareef H, Aldhaeefi M, Alrasheed T, Alrabiah A, AlBishi LA. Practical guide: Glucagon-like peptide-1 and dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonists in diabetes mellitus. World J Diabetes 2024; 15(3): 331-347 [PMID: 38591071 DOI: 10.4239/wjd.v15.i3.331] |
---|---|
URL: | https://www.wjgnet.com/1948-9358/full/v15/i3/331.htm |
Number | Citing Articles |
1 |
V. V. Salukhov, G. R. Galstyan, Iu. Sh. Khalimov, I. G. Bakulin, D. V. Cherkashin, F. E. Shadrichev, N. A. Sukhotskaia. Practical application of semaglutide: From evidence-based research to expert decisions. Meditsinskiy sovet = Medical Council 2025; (6): 14 doi: 10.21518/ms2025-185
|
2 |
Krishna S. Upadhye, Hariom Patidar, Narendra Bamnia, Narendra Yadav. HbA1c reduction strategies: An overview of pharmacological interventions. National Journal of Pharmacology and Therapeutics 2025; 3(1): 24 doi: 10.4103/NJPT.NJPT_72_24
|
3 |
Paulo César Gete Palacios, Alberto Moscona-Nissan, Renata Saucedo, Aldo Ferreira-Hermosillo. Impact on Metabolism Generated by Surgical and Pharmacological Interventions for Weight Loss in Women with Infertility. Metabolites 2025; 15(4): 260 doi: 10.3390/metabo15040260
|
4 |
Michael Horowitz, Lu Cai, Md Shahidul Islam. Glucagon-like-peptide-1 receptor agonists and the management of type 2 diabetes-backwards and forwards. World Journal of Diabetes 2024; 15(3): 326-330 doi: 10.4239/wjd.v15.i3.326
Abstract(476) |
Core Tip(540) |
Full Article(HTML)(1712)
|
Full Article with Cover (PDF)-753K(92)
|
Full Article (Word)-39K(1)
|
Audio-356K(3)
|
Peer-Review Report-229K(55)
|
Answering Reviewers-26K(50)
|
Full Article (PDF)-373K(137)
|
Full Article (XML)-49K(53)
|
Times Cited (0)
|
Total Visits (4388)
|
Open
|